Share the Video:

Considering psychedelic therapy for adolescents

Corine de Boer, Rebecca Kronman, Glauber Assis

This session explores viewpoints around the potential for psychedelic-assisted therapies to treat adolescents. Today, adolescents are using prescribed substances such as ketamine to address treatment resistant depression. Soon, the FDA may require sponsors of approved psychedelic medications to conduct additional studies with adolescents. Historically, children have ingested age-appropriate doses of plant medicines in ceremonial contexts within indigenous communities. While these treatments are promising, they must carefully assessed for risks and thoughtfully designed for use among a younger audience.

Become a MAPS Member with a monthly donation

As a Member, you’re not just making a donation — you’re joining a community that is at the forefront of advancing research, changing policy, and evolving education around psychedelics. Join us in shaping a future where these life-changing tools are available to those who need them most.

A trial of ketamine masked by surgical anesthesia in depressed patients

Ketamine and other psychedelics show promise for psychiatric disorders, but their psychoactive effects complicate masking in trials. A triple-masked trial on 40 patients with depression found surprising results.

Boris D. Heifets

PS2023 Ayahuasca Indigenous People Plant Medicine Psychedelic Assisted Therapy Research and Science Substance Use Disorder

Ayahuasca-assisted addiction treatment in Peru: results, challenges, and promises from a multi-year, mixed-methods study at Takiwasi Center

Ayahuasca's potential for treating mental disorders is explored through a study at Takiwasi Center, a Peruvian facility offering an ayahuasca-assisted addiction program. The study evaluates outcomes up to 24 months

Olivia Marcus

PS2023 Ayahuasca Depression Plant Medicine Psychedelic Assisted Therapy Research and Science

The biological antidepressant effects of Ayahuasca

Ayahuasca shows promise as a treatment for major depression, with a trial indicating significant reduction in symptoms and improvements in physiological systems linked to depression. Research on psychedelics for depression

Nicole Galvão-Coelho

PS2023 Health Conditions Indigenous People Plant Medicine Psychedelic Assisted Therapy Research and Science Substance Use Disorder

Intercultural entheogenic medicine in the treatment of addictions and other mental health challenges

Entheogens are being used in traditional Indigenous medicine practices for therapeutic purposes. Indigenous initiatives are creating intercultural clinics to offer entheogen-assisted treatments for substance use disorders and mental health challenges.

Anja Loizaga-Velder

PS2023 Anxiety Ayahuasca Depression Plant Medicine Psychedelic Assisted Therapy Research and Science

Assessing Syncretic Ayahuasca Practices Globally: Results from a multi-site cohort study of ayahuasca drinkers in non-tribal contexts

Ayahuasca, a psychoactive tea from Amazonian plants, shows promise in treating depression and grief. Urban ritual use has grown globally, including in the U.S., for addressing anxiety and depression.

Saleena Subaiya

PS2023 Depression Harm Reduction Ketamine Mental Health Psychedelic Assisted Therapy Research and Science

Panel discussion: The state of ketamine-assisted therapy

Ketamine, a WHO essential medicine, has long been used globally as an anesthetic. Its off-label use for depression is growing, sparking discussions on efficacy, safety, and regulation.

Raquel Bennet, Sunny Strasburg, Gita Vaid, Danielle M Herrera, Lauren Taus

PS2023 Indigenous People Integration Psychedelic Assisted Therapy Psychedelic Science Research and Science Therapy Ethics

Group administration and integration in psychedelic therapy

Indigenous cultures use psychedelics in group settings, contrasting with recent individual-focused psychedelic therapy research. New studies explore group administration for cost-effective care and conventional therapy benefits.

Paul Thambi, Christopher “Chris” Stauffer

PS2023 Depression Psilocybin Psychedelic Assisted Therapy Psychedelic Science Research Research and Science

How do psychedelics work?

Robin Carhart-Harris, Head of Centre for Psychedelic Research at Imperial College London, conducted pioneering clinical studies with psilocybin and other psychedelic drugs for over 40 years. He collaborates with Professor

PS2023 Ancestral Knowledge Indigenous People Integration Plant Medicine Psychedelic Science Research and Science

Opening Address - Plant Medicine Thursday

Explorers and wisdom keepers discuss benefits, challenges, and mysteries of cultivating direct relationships with plant medicines, contrasting this approach with psychedelic integration into the medical system.

Alejandra Barabas, Lorien Chaves

Considering psychedelic therapy for adolescents

Become a MAPS Member with a monthly donation

Related Videos